Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem versus fluoxetine for distal esophageal spasm
IRCT20220413054528N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of fluoxetine, diltiazem and omeprazole in Diffuse Esophageal Spasm (DES) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Improvement in clinical symptoms, Improvement in quality of life and 1 more. Started Jun 2022; status: completed.
02
Drugs
fluoxetinediltiazemomeprazole
03
Conditions
Diffuse Esophageal Spasm (DES)
Beyond the preview
Go deeper on IRCT20220413054528N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220413054528N1.